Charles Schwab Corporation (SCHW)

49.75
NYSE
Prev Close 49.79
Day Low/High 48.87 / 50.15
52 Wk Low/High 28.00 / 51.65
Exchange NYSE
Shares Outstanding 1797.21B
Market Cap 89.48B
P/E Ratio 23.05
Div & Yield N.A. (N.A)

Latest News

Does the Surge in Retail Traders Signal an Inevitable Market Collapse?

Does the Surge in Retail Traders Signal an Inevitable Market Collapse?

With the elimination of commissions, you can 'play' for free as long as you have capital.

Retail Traders Gone Wild

Wow... the data in this chart excludes Robinhood, Fidelity and a few others... Retail trading in June was largest ever GS: The top 4 online brokers ( , , , ) logged 8,079,000, the first time over 8M daily trades per day. July activity looks to excee...

Stop Rooting Against Your Stocks

Stop Rooting Against Your Stocks

The hardest part about living with covered calls is knowing that you might miss upside that exceeds your maximum net exit price -- but here are the pluses.

Jim Cramer: Non-Traditional Banks Are Starting to Pull Away From the ETFs

Jim Cramer: Non-Traditional Banks Are Starting to Pull Away From the ETFs

Overall, the banks failed you again. But the future for two of them is much brighter than the past.

A Complete Review of the Past Week's Macroeconomic Developments

Here is a summary of this week's major macroeconomic events:  The Positives  1) Moderna , while still having to progress thru phase 3 trials, reported positive antibody results from phase 1 data and brings us a step closer to that hoped for vaccine....

Charles Is Looking Like a Good Option

Charles Is Looking Like a Good Option

Charles Schwab is open for business and gaining market share.

We'll Be Checking on These Corporate Earnings Next Week

Next week the June quarter earnings season maelstrom kicks off with 115 companies, including 32 S&P 500 constituents, reporting their latest quarterly results. In recent days we've seen a number of companies up their outlook for the quarter but we'v...

It's Not a Safe Bet but Ascena Retail Has a Shot at Survival

It's Not a Safe Bet but Ascena Retail Has a Shot at Survival

The company wants to stave off a hostile takeover by an acquirer seeking to utilize the company's tax-loss carryforwards.

It's Time to Take Stock of Schwab

It's Time to Take Stock of Schwab

The long-term record of Charles Schwab tells of its future value; its current price does not.

Divining Earnings, Stunning Rebound, Trading Amazon

Divining Earnings, Stunning Rebound, Trading Amazon

Are the markets ready for a pause in this dramatic rebound? We are several weeks behind Europe in battling this pandemic and U.S. numbers are far worse. Time will tell.

A Day to Consider Charles

A Day to Consider Charles

Charles Schwab is high-quality, predictable over the long run, and exactly the type of stock to own in a major market sell-off like the one on March 9.

Jim Cramer: The Market Took a Breather. Expect More to Come

Jim Cramer: The Market Took a Breather. Expect More to Come

While some 'pruning' can be necessary, Thursday was a strange day to get clipped.

Three Strategies for Income Investors

Three Strategies for Income Investors

For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.

Consumer Spending

Kathy Jones, Chief Fixed Income Strategist at Charles Schwab , sums things up rather nicely... The sum of today's reports show consumer spending steady and import prices rising. Fed stays on hold while inflation inches higher. — Kathy Jones (@KathyJ...

Interpreting the U.S./China Trade Deal, Tax Cuts 2.0, Aerospace Stocks

Interpreting the U.S./China Trade Deal, Tax Cuts 2.0, Aerospace Stocks

Does such a large increase in Chinese spending on U.S. 'stuff' give reason to doubt that future action lives up to words on a page (or 86 pages for that matter)?

Schwab Raised at KBW

I Talk a Lot About Stocks' Performance -- Now I'll Talk About Mine

I Talk a Lot About Stocks' Performance -- Now I'll Talk About Mine

Here's a look back at how my recommendations worked out.

Big Merger Monday Conjures Up Thoughts of Potential Biotech Targets

Big Merger Monday Conjures Up Thoughts of Potential Biotech Targets

The planned acquisition of The Medicines Company by Novartis spurs prospects of other deals in the drug business.

Jim Cramer: How Robinhood Is Disrupting the Trading Landscape

Jim Cramer: How Robinhood Is Disrupting the Trading Landscape

Robinhood is bringing a whole new generation of traders into the fold.

I Got Richer By Going Broke(r)

I Got Richer By Going Broke(r)

Unlike most others, I saw AMTD's huge drop as a buying opportunity, and now look at how it turned out.

My Takeaways

* A broad-based gain today * There is a narrative for every Deal and every Bull Market -- but it always changes and sometimes it's faux (e.g. Schwab/TD Ameritrade) The steady and relentless market advance of the last seven weeks continued today. We ...

Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not

Jim Cramer: Think Stocks Are Too Pricey? These Big Takeovers Prove They're Not

We're seeing lots of companies snapping up their peers, and the market is applauding.

Those Who Went For Broke(r) Won

Those Who Went For Broke(r) Won

Buying stocks of Charles Schwab and TD Ameritrade worked out well, after the surge on Nov. 21 when it was announced that Schwab is in serious negotiations to buy AMTD.

'Dance' With E*Trade as It Searches for a Partner

'Dance' With E*Trade as It Searches for a Partner

With the potential TD Ameritrade deal, clearly E*Trade will not be 'talking to Chuck.'

Schwab and Ameritrade

I would not trade either Schwab or Ameritrade on the long side for fear of a possible antitrust issue.

Schwab Cut at Raymond James